The Effect after Intra-dermal Methylene Blue, Hydrocortisone, Lidocaine Injection Therapy for Intractable, Idiopathic Pruritus Ani
Journal of the Korean Society of Coloproctology
; : 71-75, 2005.
Article
de Ko
| WPRIM
| ID: wpr-90465
Bibliothèque responsable:
WPRO
ABSTRACT
PURPOSE: Idiopathic pruritus ani is a common and embarrassing proctological condition which can be very difficult to treat. In this study, we documented our results with methylene blue intra-dermal injection in patients with intractable idiopathic pruritus ani. METHODS: 5-ml 1% methylene blue, 100-mg hydrocortisone, and 15-ml 1% lidocaine were injected into the perianal skin of 21 patients with idiopathic pruritus ani which had proved refractory to standard care. Clinical follow-up was undertaken. RESULTS: After one injection of the above solution, 15 (71.4%) of the patients were rendered symptom free. Repeat injection in the initial non- responders ultimately rendered another four. 19 (total: 90.5 %) of the patrents symptom free. Morbidity was 0%. CONCLUSION: This study has shown that intra-dermal methylene blue injection is a safe, simple, and efficient method of treating intractable, idiopathic pruritus ani.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Prurit
/
Prurit anal
/
Peau
/
Hydrocortisone
/
Études de suivi
/
Lidocaïne
/
Bleu de méthylène
Type d'étude:
Observational_studies
/
Prognostic_studies
Limites du sujet:
Humans
langue:
Ko
Texte intégral:
Journal of the Korean Society of Coloproctology
Année:
2005
Type:
Article